Medwave Inc

Medwave — Investor Presentation (February 2005)

27 slides from Medwave's investor presentation, Feb 11, 2005

  1. Slide 1: Medwave, Inc. Sensor Based Blood Pressure Solutions

    Slide 1: Medwave, Inc. Sensor Based Blood Pressure Solutions

    Medwave, Inc. Sensor Based Blood Pressure Solutions

  2. Slide 2: Safe Harbor Statement

    Slide 2: Safe Harbor Statement

    Safe Harbor Statement As provided by the “Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995,” Medwave cautions that statements made in this presentation that are stated as expectations, plans, anticipations, prospects or future estimates or which otherwise look forward

  3. Slide 3: Company Snapshot

    Slide 3: Company Snapshot

    Company Snapshot · Currently, Medwave develops, manufactures, and sells novel technologies for non-invasive blood-pressure monitoring · The Company began as a development company with the goal of creating a faster, safer, and more accurate alternative to non-invasive blood pressure monitoring · Unli

  4. Slide 4: Medwave's Milestones

    Slide 4: Medwave's Milestones

    Medwave’s Milestones Medwave’s Milestones • Clinical studies published • New products launch • Vasotrax launch • Vasotrac early launch • 3Ci agreement • Tim O’Malley named CEO • Medwave’s IPO 19952000 • Enter prestigious medical centers • Clinical studies presented • Zoll OEM Agreement • Financing •

  5. Slide 5: Medwave Meeting Milestones

    Slide 5: Medwave Meeting Milestones

    Medwave Meeting Milestones · Tim O’Malley became CEO in Oct 1999 during Medwave’s development stage · Since that time... – The Company has raised $12.5 million. – 3 products have been developed and introduced into the market. – 11 clinical studies at prestigious medical centers have validated the Co

  6. Slide 6: Business Model

    Slide 6: Business Model

    Medwave’s Business Model · Replace blood pressure cuffs and other non-invasive monitoring devices with our superior sensor-based products in all environments: – Point of Care locations – physicians offices, point of incident, general care, skilled nursing facilities – Low end monitoring solutions –

  7. Slide 7: Blood Pressure Monitoring Devices — Sought After Characteristics

    Slide 7: Blood Pressure Monitoring Devices — Sought After Characteristics

    Blood Pressure Monitoring Devices — Sought After Characteristics - · Non-invasive / safe · Accurate · Real-time · Patient-friendly · Can accommodate a variety of patient types and environments

  8. Slide 8: Unique Product Offerings

    Slide 8: Unique Product Offerings

    Medwave’s Unique Product Offerings •Non-invasive system that provides continual blood pressure measurement with accuracy comparable to a radial artery catheter•Uses a patented method of measuring radial artery waveforms by capturing pulse pressure information during gradual direct compression of the

  9. Slide 9: Alternative Methods

    Slide 9: Alternative Methods

    Alternative Methods •Direct / Invasive Methods •Direct placement of an arterial catheter (A-line) in an artery (radial, femoral, brachial) •Advantage: accurate; can measure pulsatile waveforms with each heartbeat; real -time • Disadvantages: • Patient discomfort • Cost: approx. $1,020 per patient pe

  10. Slide 10: Advantage

    Slide 10: Advantage

    Medwave’s Advantage · Medwave’s continual non-invasive blood pressure technology offers: – Similar speed and accuracy to invasive methods · 0.97 mean correlation coefficient · Slight changes in blood pressure are detected to a low of 40mmHg and a high of 240mmHg systolic, thus accommodating a broad

  11. Slide 11: Clinical Advantage

    Slide 11: Clinical Advantage

    Medwave’s Clinical Advantage

  12. Slide 12: Automatic Cuff's Disadvantage

    Slide 12: Automatic Cuff's Disadvantage

    Automatic Cuff’s Disadvantage

  13. Slide 13: Blood Pressure Monitoring Market Size

    Slide 13: Blood Pressure Monitoring Market Size

    Blood Pressure Monitoring Market Size · Approximately 65MM Americans are considered hypertensive; this number has increased 30% in the past decade · One-third of the world’s adult population – over 1 billion – is expected to suffer from high blood pressure by 2025 · Target Market Breakdown: – Hospit

  14. Slide 14: Blood Pressure Monitoring Market Dynamics

    Slide 14: Blood Pressure Monitoring Market Dynamics

    Blood Pressure Monitoring Market Dynamics · Historically, blood pressure monitoring has been accomplished by using either an invasive arterial catheter or a blood pressure cuff: –Blood Pressure Cuffs – introduced in late 1800’s –Invasive Arterial Catheters – introduced in mid 50’s –Automatic Blood P

  15. Slide 15: Business Model — Hospital Market

    Slide 15: Business Model — Hospital Market

    Medwave’s Business Model — Hospital Market - Market Segment Primary Players Medwave Products Segment Addressed High End/ GEMS Philips, OEM Modules Systems integration Systems Draeger Bedside monitoring Mid Range GEMS Philips, OEM Module Vital signs Datascope, Welch Vasotrac Bedside monitoring Allyn,

  16. Slide 16: Recent Accomplishments — Hospital Market

    Slide 16: Recent Accomplishments — Hospital Market

    Medwave’s Recent Accomplishments — Hospital Market - · Completed 11 clinical studies validating technology across a wide spectrum of clinical environments and patient types · Introduced Disposable Sensor to create flexibility in purchase process · Built a direct sales force of 12 full-time salespeop

  17. Slide 17: Focus — Hospital Market

    Slide 17: Focus — Hospital Market

    Medwave’s Focus — Hospital Market - · Medwave’s initial commercialization attempts have been in areas where current methods of noninvasive monitoring have faced numerous challenges – Pediatrics • The size and shape of a child’s arm, as well as issues with movement and comfort, make traditional metho

  18. Slide 18: Success — Hospital Market (Pediatrics)

    Slide 18: Success — Hospital Market (Pediatrics)

    Medwave’s Success — Hospital Market - • Pediatrics – Medwave’s Vasotrac 205A participated in clinical validation studies at Children’s Hospital of Boston (OR and Cardiac ICU) and Arkansas Children’s Hospital (Pediatric ICU) and received very high ratings at both – Customer testimonial : “ Due to the

  19. Slide 19: Success — Hospital Market (Bariatrics)

    Slide 19: Success — Hospital Market (Bariatrics)

    Medwave’s Success — Hospital Market - • Bariatrics the blood pressure cuff does not fit the circumference and length of the patient’s arm, which can lead to false readings Inserting an A-line in a patient in this condition could take to 45-50 minutes and may cause serious complications medwave solut

  20. Slide 20: Business Model — Alternative Care Market

    Slide 20: Business Model — Alternative Care Market

    Medwave’s Business Model — Alternative Care Market - Market Segment Primary Players Medwave Products Segment Addressed (release 2005) Defibrillation Zoll, Physio Universal Cardiac Control, Welch OEM Module Resuscitation Allyn, Cardiac Vasotrax Science Auto-X (release 2005)(release 2005) Transport Cr

  21. Slide 21: Near-Term Goals — Alternative Care Market

    Slide 21: Near-Term Goals — Alternative Care Market

    Medwave’s Near-Term Goals - Alternative Care Market - · Enter market in 2005 –Introduce Auto-X in early 2005 directly into point of care market –Follow-up with Universal Platform in late 2005 · Hire 3 to 4 entry-level salespeople and enroll them in a 1-month intensive training program on on BP physi

  22. Slide 22: Business Model — Consumer Market

    Slide 22: Business Model — Consumer Market

    Medwave’s Business Model — Consumer Market - Primary Players Medwave Products Segment Addressed Omron, Braun, Sanyo-Auto-XAt home monitoring Electronic, Welch Allyn, Nursing care Baumometer, Other Skilled nursing (mechanical) Mobile monitoring

  23. Slide 23: Near-Term Goals — Consumer Market

    Slide 23: Near-Term Goals — Consumer Market

    Medwave’s Near-Term Goals — Consumer Market - · Clinical validation in hospital and alternative care markets will demonstrate that Medwave’s technology is superior to conventional blood pressure cuffs · Demonstrate that Medwave’s sensor technology is easier for at-home, unskilled users to administer

  24. Slide 24: Mission

    Slide 24: Mission

    Medwave’s Mission · To continue to penetrate the professional markets, with leading edge products · To become the supplier of choice for point of care, and low end vital signs monitoring solutions · To become a valued partner to the Systems Suppliers, and become a part of their larger more comprehen

  25. Slide 25: Anticipated Milestones

    Slide 25: Anticipated Milestones

    Medwave’s Anticipated Milestones · Increase revenue driven by OEM agreements and penetration of our direct sales force into automatic blood pressure and point of care markets with new products · At least 3 additional OEM agreements signed up by the end of 2005 · Gain several new high-end customers a

  26. Slide 26: Anticipated Use of Proceeds

    Slide 26: Anticipated Use of Proceeds

    Anticipated Use of Proceeds · Hire Executive Business Development employee to focus on business partnerships · Hire Chief Financial Officer · Hire additional engineering resources to implement OEM agreements and obtain additional agreements · Hire additional Hospital and Alternative Care sales profe

  27. Slide 27: Investment Highlights

    Slide 27: Investment Highlights

    Investment Highlights · Medwave is positioned for tremendous growth in the short term · Large and growing market — $2.1 billion – that needs the technology advancement and change that Medwave provides – Recent studies conclude that more than one billion people worldwide will suffer from blood pressu

Source: SEC EDGAR · 8-K filed Feb 11, 2005